Seoul National University Bundang Hospital (SNUBH)
Seoul National University Bundang Hospital (SNUBH)
République de Corée, Séoul
La clinique est certifiée :
| République de Corée | Turquie | Espagne | |
| Chimiothérapie intrapéritonéale hyperthermique (HIPEC) | de $23,500 | de $22,500 | de $25,000 |
Bookimed ne rajoute pas de frais pour les traitements de Сarcinomatose. Les tarifs proviennent des listes de prix officielles des cliniques. Vous payez directement à la clinique pour votre traitement à votre arrivée dans le pays.
Bookimed s'engage pour votre sécurité. Nous ne travaillons qu'avec des établissements médicaux qui respectent des normes internationales élevées dans le traitement de Сarcinomatose et qui possèdent les licences nécessaires pour accueillir des patients internationaux dans le monde entier.
Bookimed offre une assistance experte gratuite. Un coordinateur médical personnel vous accompagne avant, pendant et après votre traitement, en résolvant tous les problèmes. Vous n'êtes jamais seul dans votre parcours de traitement de Сarcinomatose.
South Korean hospitals treat carcinomatosis using cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC). Major centers in Seoul combine these with systemic chemotherapy and robotic-assisted procedures. JCI-accredited facilities focus on multimodal approaches for gastric, colorectal, and ovarian cancer metastasis to improve survival outcomes.
Bookimed Expert Insight: While most assume surgery is the first step, Korean university hospitals often prioritize 318,000+ annual oncology procedures. Data shows leading centers like Seoul National University Hospital use digital tracking to prevent errors. Choosing a facility with over 65,000 operations yearly ensures access to the highest surgical expertise for complex peritoneal cases.
Patient Consensus: Patients note that Korean surgeons carefully evaluate imaging and pathology before approving aggressive surgery. It is important to confirm if the hospital offers the CRS and HIPEC combination for your specific cancer type.
Korean tertiary centers achieve nearly 77% optimal debulking rates for peritoneal carcinomatosis. Complete cytoreduction (CC-0) occurs in 59% of cases. Median survival for colorectal metastasis reaches 35 months. Specialized facilities like Asan Medical Center perform over 65,000 surgeries annually with high technical precision.
Bookimed Expert Insight: Korea's infrastructure favors complex cases due to extreme digitalization and high patient volumes. Clinics like Seoul National University Bundang Hospital use the BESTcare system to minimize surgical errors. With Severance Hospital seeing 1.6 million outpatients annually, surgeons maintain high proficiency in cytoreduction. This surgical density directly correlates with the 77% optimal debulking rate reported in local studies.
Patient Consensus: Patients note that Korean surgeons focus heavily on complete cytoreduction as the primary predictor of survival. Recovery often involves significant fatigue and weight loss during the first few months after surgery.
Top Korean hospitals for peritoneal carcinomatosis include Asan Medical Center, Severance Hospital, and Seoul National University Hospital. These JCI-accredited facilities specialize in cytoreductive surgery combined with Hyperthermic Intraperitoneal Chemotherapy (HIPEC). They consistently rank among the World's Best Hospitals by Newsweek for oncology excellence.
Bookimed Expert Insight: Data shows a clear volume-based quality trend in Seoul. Asan Medical Center manages over 10,000 daily outpatients. This massive volume allows their surgical teams to specialize exclusively in peritoneal surface malignancies. For complex HIPEC procedures, this specific repetition often leads to better surgical precision than general oncology wards.
Patient Consensus: Patients note that choosing a surgeon with high case volumes for your specific cancer type is vital. They emphasize checking if the hospital has a dedicated peritoneal malignancy team rather than just a general oncology department.
The recommended stay in the Republic of Korea for CRS and HIPEC is 14 to 21 days. This window covers complex 8-hour surgery and necessary hospitalization. You must remain until stable for long-haul travel. Most patients stay in the hospital for 10 to 14 days.
Bookimed Expert Insight: Korea's major centers like Asan Medical Center and SNUH operate at massive scale, managing thousands of patients daily. This high volume means post-surgical protocols are extremely standardized. We notice that patients often need 3 to 5 extra days in a nearby hotel after hospital discharge. This buffer ensures you are eating and walking well before a long flight.
Patient Consensus: Patients emphasize that regain of bowel function and hydration levels determines when you can actually fly. They recommend booking flexible return tickets because recovery speed varies significantly between individuals.
South Korean specialty hospitals provide English-speaking doctors and dedicated coordinators for international carcinomatosis patients. Leading centers in Seoul maintain JCI-accredited departments specifically for medical tourists. These teams handle appointment logistics, medical translations, and multidisciplinary coordination for complex treatments like HIPEC.
Bookimed Expert Insight: While top oncologists often speak English, the high volume at clinics like Asan Medical Center—serving 11,800 outpatients daily—makes the dedicated international coordinator essential. These staff members ensure your HIPEC protocol details aren't lost in translation during busy shifts. Check if your chosen clinic has JCI or GHA accreditation to guarantee these communication standards.
Patient Consensus: Patients note that while lead surgeons often have high fluency, navigating nursing care and billing requires the hospital's dedicated translation support. Most recommend confirming a personal coordinator is assigned before traveling for intensive cancer treatments.